---
handoff_id: "CR161-CP3-META-SE-HANDOFF-2026-07-09"
cr_id: "CR-161"
from: "host-orchestrator"
to: "meta-se-critical"
phase: "solution-design"
status: "completed"
created_at: "2026-07-09T22:19:04+08:00"
completed_at: "2026-07-09T22:35:27+08:00"
context_ref: "process/context/CP3-CR161-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING-DESIGN-CONTEXT.yaml"
dispatch:
  mode: "subagent"
  canonical_role: "meta-se"
  codex_agent_name: "meta-se-critical"
  reasoning_profile: "critical"
  dispatch_trigger: "public evidence contract, cross-strategy admission boundary, major ADR"
  tool_name: "spawn_agent"
  agent_id: "019f4742-3dda-7253-b655-e83ae57e2b25"
  agent_name: "se-critical-wei"
  status: "completed"
  completed_at: "2026-07-09T22:35:27+08:00"
---

# CR161 CP3 Meta-SE Handoff

## Objective

Produce CR161 CP3 design artifacts for the approved contract-first strategy admission evidence hardening slice.

## Required Context

- `process/context/CP3-CR161-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING-DESIGN-CONTEXT.yaml`
- `process/checkpoints/CP2-CR161-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING-SCOPE.md`
- `process/checks/CP2-CR161-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING-SCOPE.result.json`

## Required Outputs

- `docs/design/HLD-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING.md`
- `docs/design/ARCHITECTURE-DECISION-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING.md`
- `process/discussions/CP3-CR161-HLD-DISCUSSION-LOG.md`
- `process/checks/CP3-CR161-DISCUSSION-CHECKPOINT.json`
- `process/checks/CP3-CR161-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING-HLD-CONSISTENCY.result.json`

## Hard Requirements

- Include an explicit 7-object evidence coverage matrix:
  - `ExperimentFamilyManifest`
  - `MultipleTestingEvidence`
  - `DataSnoopingEvidence`
  - `OverfitRiskEvidence`
  - `WalkForwardEvidence`
  - `EconomicCostEvidence`
  - `CapacityLiquidityEvidence`
- State that the current slice delivers `typed_unavailable` fail-closed contract semantics, not computable FDR/PBO/DSR, fold-level OOS computation, real TCA, or capacity implementation.
- Integrate through CR151/CR154 evidence refs/summaries; do not create a parallel gate family.
- Preserve CR155 as blocked negative regression only.
- Do not modify source code or tests.
- Do not authorize runtime, real lake/NAS/provider/credential, broker/trading, external framework, Git remote write, publish, or true release execution.
